EVSD yields 4.65% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, EVSD + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of EVSD + PFE for your $10,000?
EVSD launched through the conversion of the MSIFT Short Duration Income Portfolio mutual fund that was holding $141.3 million in assets. The ETF may hold any type of fixed income security, while aiming to maintain an average duration of three years or less. The active management process includes a proprietary multi-sector, top-down/bottom-up evaluation and selection process. The advisor relies on valuation metrics such as, level of real interest rates, yield curve slopes, and credit-adjusted spreads to guide investment decisions including, country, sector, and security exposure. ESG issues may be taken into consideration. The fund may hold securities of foreign issuers, including those in emerging markets, although only US dollar-denominated securities are expected to be held in the fund. Derivatives, both exchange-traded and over-the-counter options, may be utilized at the advisers discretion to help provide similar underlying exposure or to hedge portfolio risk.
Full EVSD Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.